drugset / Trial / NCT05823870
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of DW6014 and each component in healthy adult volunteers in fast condition.
Timeline
- Start
- 2023-02-24
- Primary completion
- 2023-03-06
- Completion
- 2023-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW6014 | Unknown | — | Oral |
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
Indications
No indication recorded.